mRNA licensing agreements surge 800% amid GSK lawsuits

By Yahoo! Finance | Oct 18, 2024 at 04:26 PM EST

The success of mRNA technology in Covid-19 vaccines has led to an 800% increase in licensing deal values for mRNA-based pharmaceuticals. Major companies are heavily investing in mRNA technology, but recent lawsuits by GSK against Pfizer, BioNTech, and Moderna have raised concerns.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.